Workflow
灵康药业: 关于董事会提议向下修正“灵康转债”转股价格的公告

Core Viewpoint - The board of directors of Lingkang Pharmaceutical Group Co., Ltd. proposes to lower the conversion price of "Lingkang Convertible Bonds" due to the stock price being below 85% of the current conversion price for at least 15 out of the last 30 trading days [1][4]. Summary by Sections 1. Basic Information of Convertible Bonds - Lingkang Pharmaceutical issued 5.25 million convertible bonds on December 1, 2020, with a face value of 100 yuan each, totaling 525 million yuan [2]. - The bonds are traded under the name "Lingkang Convertible Bonds" with the code "113610" [2]. 2. Conversion Price Adjustment Terms and Trigger Conditions - The conversion price can be adjusted if the stock price is below the current conversion price for at least 15 out of 30 consecutive trading days [3]. - The initial conversion price was set at 8.81 yuan per share, with the latest adjustment bringing it down to 8.00 yuan per share [2]. 3. Procedures for Price Adjustment Proposal - The board meeting on July 14, 2025, approved the proposal to lower the conversion price and will submit it to the shareholders' meeting for approval [4]. - The adjusted conversion price must not be lower than the higher of the average stock price over the 20 trading days prior to the shareholders' meeting and the previous trading day's average [5].